Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
Details for Australian Patent Application No. 2005215213 (hide)
International Classifications
Event Publications
5 October 2006 PCT application entered the National Phase
PCT publication WO2005/079822 Priority application(s): WO2005/079822
1 July 2010 Assignment before Grant
Intercytex Limited The application has been assigned to DFB Technology Holdings, LLC
9 September 2010 Application Accepted
Published as AU-B-2005215213
6 January 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 06 Dec 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2006
28 April 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Dec 2010
12 May 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser